Aegicare is a genomic intelligence company empowering precision medicine, from high-throughput diagnosis to innovative therapeutics. With our first-in-class clinical lab and AEGIS genomic intelligence platform powered by cutting-edge natural language processing, bioinformatics and deep learning algorithms, we make genetic information more affordable and accessible, we facilitate better clinical decisions, and we revolutionize the process for genome based drug discovery. Nearly 4% of the world’s population are suffering from genetic diseases that do not have a cure, around 80~95% of people need to try multiple drug in order to find one that’s effective, even more strikingly, millions of people are hospitalized annually due to adverse side effects from medications, resulting in hundreds of thousands of deaths per year. These highlight the critical need for precision medicine. Recent breakthroughs in the life sciences and artificial intelligence technology make the interpretation of the explosive amount of omics data possible, and this allows us to develop tailored treatment for each individual, and guide more accurate, proactive and impactful healthcare for billions of people.